|
|
Article: Aldara.(anticancer drugs)(Brief Article)
- Article from:
- Medical Marketing & Media
- Article date:
- September 1, 2004
CopyrightCOPYRIGHT 2004 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Aldara (imiquimod) topical cream has received FDA approval for use in treating superficial basal cell carcinoma--a type of skin cancer--except on the face. This is a new indication for ...
Related newspaper, magazine, and journal articles:
|
|
Article: NEOPHARM OFFERING SEEKS $55M FOR TRIALS OF ANTICANCER ...
BIOWORLD Today;
August 25, 2000 ;
700+ words
...NeoPharm Inc. is seeking to raise more than $55 million in its first public offering since moving from the Amex to the Nasdaq exchange in April. The 2.8-million-share offering would raise $60.2 million at NeoPharm's Thursday closing price (NASDAQ:NEOL) of $21.50, which was up $2.125, or 11 percent,
|
|